arrow
D

Daniel Knight

national pulmonary hypertension service royal free london nhs foundation trust
H指数:32
被引数:4,508

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Exploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders – The EXCALIBUR study

利用植入式环状记录仪探索心脏淀粉样变性中的心律失常负担——EXCALIBUR研究

JACC
IF0
2026-05-100
OAAI
Atrial Mechanical Contraction Predicts Cerebrovascular Risk in Patients With Transthyretin Amyloid Cardiomyopathy and Sinus Rhythm

心房机械收缩预测转甲状腺素蛋白淀粉样变性心肌病合并窦性心律患者的脑血管风险

JACC
IF0
2026-02-180
OAAI
Myocardial Amyloid Burden in Transthyretin Amyloidosis

转甲状腺素蛋白淀粉样变性中的心肌淀粉样蛋白负荷

JACC
IF0
2025-11-080
OAAI
Transthyretin amyloid cardiomyopathy: natural history and treatment response assessed by cardiovascular magnetic resonance

Patel, R.K.; Ioannou, A.; Sheikh, A.; Razvi, Y.; Mansell, J.; Martinez-Naharro, A.; Knight, D.; Kotecha, T.; Porcari, A.; Chacko, L.; 等. 甲状腺素转运蛋白淀粉样变性心肌病:基于心血管磁共振的自然病程及治疗反应评估。Eur. Heart J. 2025, ehaf412. [Google Scholar] [CrossRef] [PubMed]

2025-07-014
OAAI
Cardiopulmonary Exercise Testing in Evaluating Transthyretin Amyloidosis
2024-04-013
PRE
Deep phenotyping of p.(V142I)-associated variant transthyretin amyloid cardiomyopathy: Distinct from wild-type transthyretin amyloidosis?

p.(V142I) 相关变异型甲状腺素运载蛋白淀粉样心肌病的深度表型: 与野生型甲状腺素运载蛋白淀粉样变性不同?

2024-01-2810
OA
Myocardial perfusion in cardiac amyloidosis
2024-01-216
OA
Redefining Cardiac Involvement in Systemic Immunoglobulin Light Chain Amyloidosis and Treatment Implications
2023-11-070
PRE
Tracking Treatment Response in Cardiac Light-Chain Amyloidosis With Native T1 Mapping
2023-09-0114
OAAI
British Society of Echocardiography guideline for the transthoracic echocardiographic assessment of cardiac amyloidosis

英国超声心动图学会心脏淀粉样变性经胸超声心动图评估指南

2023-08-3110
OAAI
Tracking Multiorgan Treatment Response in Systemic AL-Amyloidosis With Cardiac Magnetic Resonance Derived Extracellular Volume Mapping
2023-08-0113
OAAI
Conventional heart failure therapy in cardiac ATTR amyloidosis

心脏ATTR淀粉样变性的常规心力衰竭治疗

2023-05-2242
OAAI